Drug Shortage Report for TRILEPTAL 600 MG

Last updated on 2023-04-13 History
Report ID 175429
Drug Identification Number 02242069
Brand name TRILEPTAL 600 MG
Common or Proper name TRILEPTAL 600 MG
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) OXCARBAZEPINE
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 5X10
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-11-30
Actual start date 2023-01-27
Estimated end date 2023-01-31
Actual end date 2023-02-08
Shortage status Resolved
Updated date 2023-04-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-04-13 French Compare
v6 2023-04-13 English Compare
v5 2022-12-01 English Compare
v4 2022-11-22 French Compare
v3 2022-11-22 English Compare
v2 2022-11-22 French Compare
v1 2022-11-22 English Compare

Showing 1 to 7 of 7